UNITED THERAPEUTICS Corp Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in UNITED THERAPEUTICS Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in UNITED THERAPEUTICS Corp for March 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 52.65 | 21,512 | 1,132,607 | 256,246 | |
| Mar 30 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 52.65 | 21,512 | 1,132,607 | 277,758 | |
| Mar 30 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 112.29 | 9,512 | 1,068,122 | 140 | 9.7 K to 140 (-98.55 %) |
| Mar 30 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 111.78 | 9,210 | 1,029,519 | 9,652 | 18.9 K to 9.7 K (-48.83 %) |
| Mar 30 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 110.41 | 2,790 | 308,037 | 18,862 | 21.7 K to 18.9 K (-12.89 %) |
| Mar 30 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 52.65 | 21,512 | 1,132,607 | 21,652 | 140 to 21.7 K (+15,365.71 %) |
| Mar 30 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 111.18 | 1,100 | 122,301 | 140 | 1.2 K to 140 (-88.71 %) |
| Mar 30 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 110.42 | 20,412 | 2,253,832 | 1,240 | 21.7 K to 1.2 K (-94.27 %) |
| Mar 30 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 52.65 | 21,512 | 1,132,607 | 21,652 | 140 to 21.7 K (+15,365.71 %) |
| Mar 23 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 52.65 | 500 | 26,325 | 299,270 | |
| Mar 23 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 110.00 | 500 | 55,000 | 140 | 640 to 140 (-78.12 %) |
| Mar 23 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 52.65 | 500 | 26,325 | 640 | 140 to 640 (+357.14 %) |
| Mar 23 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 52.65 | 1,100 | 57,915 | 299,770 | |
| Mar 23 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 110.10 | 100 | 11,010 | 140 | 240 to 140 (-41.67 %) |
| Mar 23 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 110.02 | 200 | 22,004 | 240 | 440 to 240 (-45.45 %) |
| Mar 23 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 110.00 | 800 | 88,000 | 440 | 1.2 K to 440 (-64.52 %) |
| Mar 23 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 52.65 | 1,100 | 57,915 | 1,240 | 140 to 1.2 K (+785.71 %) |
| Mar 21 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 52.65 | 301 | 15,848 | 300,870 | |
| Mar 21 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 52.65 | 21,512 | 1,132,607 | 301,171 | |
| Mar 21 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 111.10 | 1 | 111 | 140 | 141 to 140 (-0.71 %) |
| Mar 21 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 110.52 | 100 | 11,052 | 141 | 241 to 141 (-41.49 %) |
| Mar 21 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 110.48 | 100 | 11,048 | 241 | 341 to 241 (-29.33 %) |
| Mar 21 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 110.44 | 100 | 11,044 | 341 | 441 to 341 (-22.68 %) |
| Mar 21 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 52.65 | 301 | 15,848 | 441 | 140 to 441 (+215.00 %) |
| Mar 21 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 111.61 | 122 | 13,616 | 140 | 262 to 140 (-46.56 %) |
| Mar 21 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 110.03 | 21,390 | 2,353,443 | 262 | 21.7 K to 262 (-98.79 %) |
| Mar 21 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 52.65 | 21,512 | 1,132,607 | 21,652 | 140 to 21.7 K (+15,365.71 %) |
| Mar 16 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 52.65 | 21,513 | 1,132,659 | 322,683 | |
| Mar 16 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 52.65 | 21,512 | 1,132,607 | 344,196 | |
| Mar 16 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 111.87 | 8,369 | 936,251 | 140 | 8.5 K to 140 (-98.35 %) |
| Mar 16 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 52.65 | 21,513 | 1,132,659 | 322,683 | |
| Mar 16 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 111.02 | 13,144 | 1,459,230 | 8,509 | 21.7 K to 8.5 K (-60.70 %) |
| Mar 16 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 52.65 | 21,512 | 1,132,607 | 344,196 | |
| Mar 16 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 52.65 | 21,513 | 1,132,659 | 21,653 | 140 to 21.7 K (+15,366.43 %) |
| Mar 16 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 111.87 | 8,369 | 936,251 | 140 | 8.5 K to 140 (-98.35 %) |
| Mar 16 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 112.33 | 100 | 11,233 | 140 | 240 to 140 (-41.67 %) |
| Mar 16 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 111.02 | 13,144 | 1,459,230 | 8,509 | 21.7 K to 8.5 K (-60.70 %) |
| Mar 16 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 111.41 | 1,800 | 200,541 | 240 | 2 K to 240 (-88.24 %) |
| Mar 16 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 52.65 | 21,513 | 1,132,659 | 21,653 | 140 to 21.7 K (+15,366.43 %) |
| Mar 16 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 110.82 | 19,612 | 2,173,314 | 2,040 | 21.7 K to 2 K (-90.58 %) |
| Mar 16 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 112.33 | 100 | 11,233 | 140 | 240 to 140 (-41.67 %) |
| Mar 16 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 52.65 | 21,512 | 1,132,607 | 21,652 | 140 to 21.7 K (+15,365.71 %) |
| Mar 16 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 111.41 | 1,800 | 200,541 | 240 | 2 K to 240 (-88.24 %) |
| Mar 16 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 110.82 | 19,612 | 2,173,314 | 2,040 | 21.7 K to 2 K (-90.58 %) |
| Mar 16 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 52.65 | 21,512 | 1,132,607 | 21,652 | 140 to 21.7 K (+15,365.71 %) |
| Mar 16 2018 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Option Exercise | M | 65.80 | 6,000 | 394,800 | 45,500 | |
| Mar 16 2018 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Sell | D | 111.00 | 6,000 | 666,000 | 35,613 | 41.6 K to 35.6 K (-14.42 %) |
| Mar 16 2018 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Buy | M | 65.80 | 6,000 | 394,800 | 41,613 | 35.6 K to 41.6 K (+16.85 %) |
| Mar 14 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 52.65 | 21,512 | 1,132,607 | 387,220 | |
| Mar 14 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 52.65 | 21,512 | 1,132,607 | 408,732 | |
| Mar 14 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 116.51 | 200 | 23,302 | 140 | 340 to 140 (-58.82 %) |
| Mar 14 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 115.54 | 4,502 | 520,160 | 340 | 4.8 K to 340 (-92.98 %) |
| Mar 14 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 114.62 | 6,590 | 755,341 | 4,842 | 11.4 K to 4.8 K (-57.65 %) |
| Mar 14 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 113.59 | 10,220 | 1,160,845 | 11,432 | 21.7 K to 11.4 K (-47.20 %) |
| Mar 14 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 52.65 | 21,512 | 1,132,607 | 21,652 | 140 to 21.7 K (+15,365.71 %) |
| Mar 14 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 116.58 | 20 | 2,332 | 140 | 160 to 140 (-12.50 %) |
| Mar 14 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 116.00 | 16,179 | 1,876,678 | 160 | 16.3 K to 160 (-99.02 %) |
| Mar 14 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 115.18 | 5,313 | 611,968 | 16,339 | 21.7 K to 16.3 K (-24.54 %) |
| Mar 14 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 52.65 | 21,512 | 1,132,607 | 21,652 | 140 to 21.7 K (+15,365.71 %) |
| Mar 14 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Option Exercise | M | 52.65 | 21,512 | 1,132,607 | 365,708 | |
| Mar 14 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 114.05 | 2,470 | 281,714 | 140 | 2.6 K to 140 (-94.64 %) |
| Mar 14 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 113.07 | 5,267 | 595,530 | 2,610 | 7.9 K to 2.6 K (-66.87 %) |
| Mar 14 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Sell | S | 112.09 | 13,775 | 1,544,018 | 7,877 | 21.7 K to 7.9 K (-63.62 %) |
| Mar 14 2018 | UTHR | UNITED THERAPEUTIC ... | ROTHBLATT MARTINE A | Chairman & CEO | Buy | M | 52.65 | 21,512 | 1,132,607 | 21,652 | 140 to 21.7 K (+15,365.71 %) |
| Mar 09 2018 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Option Exercise | M | 54.77 | 750 | 41,078 | 6,000 | |
| Mar 09 2018 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Sell | D | 115.36 | 750 | 86,520 | 1,555 | 2.3 K to 1.6 K (-32.54 %) |
| Mar 09 2018 | UTHR | UNITED THERAPEUTIC ... | CAUSEY CHRISTOPHER | Director | Buy | M | 54.77 | 750 | 41,078 | 2,305 | 1.6 K to 2.3 K (+48.23 %) |
| Mar 05 2018 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Option Exercise | M | 61.06 | 6,000 | 366,360 | 91,000 | |
| Mar 05 2018 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Sell | D | 113.56 | 6,000 | 681,360 | 35,426 | 41.4 K to 35.4 K (-14.48 %) |
| Mar 05 2018 | UTHR | UNITED THERAPEUTIC ... | MAHON PAUL A | EVP & General Couns ... | Buy | M | 61.06 | 6,000 | 366,360 | 41,426 | 35.4 K to 41.4 K (+16.94 %) |